High-dose-rate brachytherapy for large prostate volumes (≥50cc)—Uncompromised dosimetric coverage and acceptable toxicity

Purpose The purpose of this study was to review our single-institution experience using high-dose-rate (HDR) brachytherapy in patients with large-volume prostate glands (≥50 cc). Methods and materials Fifty-four patients treated with HDR brachytherapy for prostate cancer at the Penrose Cancer Center between 2001 and 2006 were identified as having an ultrasound volume of at least 50 cc at the time of implant (range, 50–97.3 cc; mean, 61.5 cc;...